Ask Me About My Research with Dr. Jacob Reimer
In this video, Dr. Jacob Reimer, assistant professor of neuroscience, shares with a student from BCM Biotech Academy at Ryan his work studying the brain’s ability to focus.
Read More
From The Labs
Texas Children’s/Baylor researchers developed new tool to improve accuracy of genetic testing
The tool offers a new way to measure genetic variants in the Genome Aggregation Database (gnomAD), one of the world’s most widely used resources for understanding human genetics.
Read More
Need to optimize drug design? COOKIE-Pro can help.
With COOKIE-Pro drug designers can see for the first time not just if a drug binds off-target, but how well and how fast.
Read More
NIH awards Baylor more than $15 million to fund two rare diseases consortia
The funding is to renew the Brittle Bone Disorders Consortium for five years and to launch the Rare Organic Acidemias Research Consortium.
Read More
Collaboration to Advance Immune-Targeted Drug Discovery at Baylor College of Medicine
The collaboration to develop novel small-molecule drugs allows for the fine-tuning of immune responses in multiple diseases.
Read More
Exercise is not just about burning calories; it also reduces appetite and here is how
The results suggest the exciting possibility of targeting this newly discovered mechanism for weight management.
Read More
Breast cancer clues hint at response to therapy in animal models
The findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.
Read More
Baylor researchers uncovered how physical activity helps improve memory in Alzheimer’s disease
The findings open new possibilities for future treatments to prevent or treat the condition.
Read More
Ask Me About My Research with Dr. Felipe Andrés Piedra
Dr. Felipe Andrés Piedra shares with a student from BCM Biotech Academy at Rusk his work training bacteria to eat plastic, aiding in the effort to create a cleaner, healthier world.
Read More
AI connects mutations, protein modifications and disease
The new AI tool, called DeepMVP, significantly outperforms previously published models and has implications for the development of novel therapeutics.
Read More